Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-135999

Published: 2020

Journal Articles

Long-Term Efficacy and Safety Results of CT-P10 and Reference Rituximab in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma: Phase III Updated Study Results with Median Follow-up of 40 Months

Christian Buske, MD PhD, Larry W Kwak, MD PhD, Wojciech Jurczak, MD PhD, Juan-Manuel Sancho, MD PhD, Edvard Zhavrid, MD PhD, Jin Seok Kim, MD PhD, Jose Angel Hernandez-Rivas, MD PhD, Aliaksandr Prokharau, MD PhD, Mariana Vasilica, MD PhD, Rajnish Nagarkar, MD PhD, Gayane Tumyan, DMSc, MD PhD, Won-Seog Kim, MD PhD, Michinori Ogura, MD PhD, Sang Joon Lee, PhD, Sung Hyun Kim, PhD, Keum Young Ahn, PhD

Blood (2019) 134 (Supplement_1): 1528.

https://doi.org/10.1182/blood-2019-126379

Published: 2019

Journal Articles

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Bertrand Coiffier, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas, Aliaksandr Prokharau, Mamia Zodelava, Dzhelil Osmanov, Michinori Ogura, Christian Buske, Larry Kwak, Sang Joon Lee, Sung Young Lee, Yun Ju Bae, Won Seog Kim

Blood (2016) 128 (22): 1807.

https://doi.org/10.1182/blood.V128.22.1807.1807

Published: 2016

Journal Articles

Survival Outcomes of Adults with Acute Myeloid Leukemia – A Study of Native American, Hispanic, and Non-Hispanic Whites Treated In New Mexico (1986 to 2006)

Nancy Rivera, Beeling Armijo, Dulcinea Quintana, M.D., Maryam Abdul-Jaleel, M.D., Sang-Joon Lee, PhD, Charles Wiggins, PhD, Edward Libby, MD

Blood (2010) 116 (21): 4365.

https://doi.org/10.1182/blood.V116.21.4365.4365

Published: 2010

Journal Articles

Clonal heterogeneity in mycosis fungoides and its relationship to clinical course

Francisco Vega, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Valerie Dunmire, Sang-Joon Lee, Madeleine Duvic, Dan Jones

Blood (2002) 100 (9): 3369–3373.

https://doi.org/10.1182/blood.V100.9.3369

Published: 2002

NARROW

Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Long-Term Efficacy and Safety Results of CT-P10 and Reference Rituximab in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma: Phase III Updated Study Results with Median Follow-up of 40 Months

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Survival Outcomes of Adults with Acute Myeloid Leukemia – A Study of Native American, Hispanic, and Non-Hispanic Whites Treated In New Mexico (1986 to 2006)

Clonal heterogeneity in mycosis fungoides and its relationship to clinical course

Email alerts

ASH Publications

American Society of Hematology

Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma

Long-Term Efficacy and Safety Results of CT-P10 and Reference Rituximab in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma: Phase III Updated Study Results with Median Follow-up of 40 Months

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Survival Outcomes of Adults with Acute Myeloid Leukemia – A Study of Native American, Hispanic, and Non-Hispanic Whites Treated In New Mexico (1986 to 2006)

Clonal heterogeneity in mycosis fungoides and its relationship to clinical course

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only